Risperdal Side Effects – Gynecomastia (Male Breast Growth)
If you or a loved one has taken Risperdal and as a result suffered any number of irreversible side effects such as gynecomastia you may be able to hold the dangerous drug companies responsible for your pain and suffering.
About Risperdal
Risperdal, approved by the FDA in 1993, is an antipsychotic medication used to treat the symptoms of schizophrenia in adults and teenagers 13 years and older. Lower dosages of Risperdal are often prescribed to children in the treatment of autism, ADHD, forms of bipolar disorder, obsessive-compulsive disorder, psychotic depression and Tourettes syndrome.
However, most recently Risperdal has been linked to many serious side effects such as gynecomastia. Risperdal has been found to increase a hormone called prolactin which stimulates breast growth. Male breast growth, a condition known as gynecomastia, has been seen in boys taking the drug Risperdal. The condition is usually permanent, and in most cases, boys with Risperdal-associated gynecomastia must undergo breast reduction surgery or mastectomy to correct the problem which is a very painful surgery.
Other Riserpdal side effects include:
- Hyperglycemia
- Risperdal diabetes
- Hyperosmolar Coma
- Heart attack
- Tardive Dyskinesis
- Stroke
- Gynecomastia (Male Breast Growth)
As a result of these potentially deadly Risperdal side effects, the FDA has asked manufacturers to include a warning statement describing the increased risk of hyperglycemia and diabetes, including possible or hyperosmolar coma or death.
If you or a loved one has been personally injured due to Risperdal associated gynecomastia side effects we urge you to contact our Risperdal lawyers so we can fight for you. Let us hold the dangerous drug companies accountable for any pain and suffering you may have endured with the diagnosis of Gynecomastia, as a side effect of Rispideral.
If you or a loved one took Risperdal and suffered side effects, please contact our law firm at 1-800-BAD-DRUG for a free consultation.
